Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.

Learn more about anxiety medications. The first line of treatment for depression is antidepressant medication. Some people may need a combination of drugs to best manage their condition.

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...

Focusing treatments for depression and anxiety to gut cells instead of brain cells may help people feel better without side effects.

Depression affects millions of Americans every year, and the challenges can feel even more overwhelming during the holiday ...

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

The US Food and Drug Administration had just approved VNS in 2005 for the long-term adjunctive treatment of chronic or ...

Research reveals new connections between the gut and brain, suggesting more targeted depression and anxiety treatments, and a ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Relmada halted Phase 3 trials of NMDA receptor blocker for depression but will continue its early psilocybin program while ...

A systemic review found that, on average, 36 percent of people living with schizophrenia met the criteria for treatment ...